Clinique and Mount Sinai partner to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center

Two cen­tral ner­vous sys­tem dis­or­der biotechs laid off em­ploy­ees re­cent­ly. New York gene ther­a­py start­up Aper­tu­ra and Boston RNAi biotech Ata­lan­ta Ther­a­peu­tics have trimmed their

Tourmaline reported total cash reserves of $218m, which is expected to provide a cash runway through 2026. Image Credit: Gorodenkoff / Shutterstock. Tourmaline Bio has